Latest Breaking News On - Marites coulter - Page 1 : comparemela.com

ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials

ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomEmanuele ostuniPatrick schmidtMarites coulterCharless conroyNucleus radiopharma incArtbio incUniversity of osloNucleus radiopharmaChief executive officerBusiness wire

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

SEATTLE and CAMBRIDGE, United Kingdom, July 20, 2023 Eliem Therapeutics, Inc. today announced that it has completed a review of its business, including the status of its programs, resources,.

United kingdomChris brinzeyMarites coulterEliem therapeutics incLeerink partnersEliem therapeuticsQuarterly report

Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

Presented initial preclinical data from ETX-123, Eliem s lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed mechanism of action on neuronal excitability . | May 11, 2023

United kingdomChris brinzeyMarites coulterAndrew levinEliem therapeutics incProgram updatesInternational kvEpilepsy therapies diagnostics developmentIon channelsTherapeutic targetsEpilepsy therapiesDiagnostics developmentAnticipated keyEliem therapeuticsQuarterly reportConsolidated statements

Eliem Therapeutics Reports First Quarter Financial Results

Presented initial preclinical data from ETX-123, Eliem's lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed.

United kingdomAndrew levinChris brinzeyMarites coulterInternational kvEliem therapeutics incEpilepsy therapies diagnostics developmentProgram updatesIon channelsTherapeutic targetsEpilepsy therapiesDiagnostics developmentAnticipated keyEliem therapeuticsQuarterly reportConsolidated statements

Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference

30.11.2022 - SEATTLE and CAMBRIDGE, United Kingdom, Nov. 30, 2022 (GLOBE NEWSWIRE) - Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet .

Marites coulterChris brinzeyEliem therapeutics incAbout eliem therapeutics